Infinity Fundamentals

INFI -  USA Stock  

USD 0.73  0.10  12.05%

Infinity Pharmaceuti fundamentals help investors to digest information that contributes to Infinity Pharmaceuti's financial success or failures. It also enables traders to predict the movement of Infinity Stock. The fundamental analysis module provides a way to measure Infinity Pharmaceuti's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Infinity Pharmaceuti stock. This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools.
  
Refresh
Infinity Pharmaceuti Operating Expenses is most likely to decrease significantly in the upcoming years. The last year's value of Operating Expenses was reported at 46.94 Million. The current Revenues is estimated to increase to about 1.9 M, while Consolidated Income is projected to decrease to (48.8 M).

Infinity Current Liabilities Analysis

Infinity Pharmaceuti's Current Liabilities is the company's short term debt. This usually includes obligations that are due within the next 12 months or within one fiscal year. Current liabilities are very important in analyzing a company's financial health as it requires the company to convert some of its current assets into cash.

Infinity Pharmaceuti Current Liabilities

17.41 Million

Share
Current Liabilities 
 = 
Payables 
Accrued Debt 
More About Current Liabilities | All Equity Analysis

Current Infinity Pharmaceuti Current Liabilities

    
  70.06 M  
Most of Infinity Pharmaceuti's fundamental indicators, such as Current Liabilities, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Infinity Pharmaceuti is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.

Infinity Current Liabilities Historical Pattern

Today, most investors in Infinity Pharmaceuti Stock are looking for potential investment opportunities by analyzing not only static indicators but also various Infinity Pharmaceuti's growth ratios. Consistent increases or drops in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's current liabilities growth rates may not be enough to decide which company is a better investment. That's why investors frequently use a static breakdown of Infinity Pharmaceuti current liabilities as a starting point in their analysis.
 Infinity Pharmaceuti Current Liabilities 
Share
      Timeline 
Current liabilities appear on the company's balance sheet and include all short term debt accounts, accounts and notes payable, accrued liabilities as well as current payments due on the long-term loans. One of the most useful applications of Current Liabilities is the current ratio which is defined as current assets divided by its current liabilities. High current ratios mean that current assets are more than sufficient to pay off current liabilities.
Compare to competition

Infinity Total Liabilities

Total Liabilities

61.72 Million

Share
Infinity Pharmaceuti Total Liabilities is most likely to decrease significantly in the upcoming years. The last year's value of Total Liabilities was reported at 63.21 Million
In accordance with the recently published financial statements, Infinity Pharmaceuti has a Current Liabilities of 70.06 M. This is 96.0% lower than that of the Healthcare sector and 87.1% lower than that of the Biotechnology industry. The current liabilities for all United States stocks is 99.11% higher than that of the company.

Infinity Pharmaceuti Fundamental Drivers Relationships

Comparative valuation techniques use various fundamental indicators to help in determining Infinity Pharmaceuti's current stock value. Our valuation model uses many indicators to compare Infinity Pharmaceuti value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Infinity Pharmaceuti competition to find correlations between indicators driving Infinity Pharmaceuti's intrinsic value. More Info.
Infinity Pharmaceuti is currently regarded as number one stock in working capital category among related companies. It is currently regarded as number one stock in short ratio category among related companies . The ratio of Working Capital to Short Ratio for Infinity Pharmaceuti is about  33,328,700 . Infinity Pharmaceuti Working Capital is most likely to decrease significantly in the upcoming years. The last year's value of Working Capital was reported at 68.97 Million. Comparative valuation analysis is a catch-all model that can be used if you cannot value Infinity Pharmaceuti by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Infinity Pharmaceuti's Stock . Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Infinity Pharmaceuti's earnings, one of the primary drivers of an investment's value.

Infinity Earnings Per Share Peer Comparison

Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Infinity Pharmaceuti's direct or indirect competition against its Earnings Per Share to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Infinity Pharmaceuti could also be used in its relative valuation, which is a method of valuing Infinity Pharmaceuti by comparing valuation metrics of similar companies.
Infinity Pharmaceuti is currently under evaluation in earnings per share category among related companies.

Infinity Pharmaceuti Current Valuation Drivers

We derive many important indicators used in calculating different scores of Infinity Pharmaceuti from analyzing Infinity Pharmaceuti's financial statements. These drivers represent accounts that assess Infinity Pharmaceuti's ability to generate profits relative to its revenue, operating costs, and shareholders' equity. Below are some of Infinity Pharmaceuti's important valuation drivers and their relationship over time.
201720182019202020212022 (projected)
Net Income Per Employee(1.9 M)(450.12 K)(1.88 M)(1.76 M)(2.02 M)(2.07 M)
Revenue Per Employee272.73 K885.84 K121.96 K74.53 K85.72 K87.97 K
Average Assets79.52 M56.84 M62.83 M48.01 M98.6 M115.5 M
Earnings Before Interest Taxes and Depreciation Amortization EBITDA(39.83 M)(10.97 M)(44.33 M)(37.56 M)(44.6 M)(48.12 M)
Earnings Before Interest Taxes and Depreciation Amortization USD(39.83 M)(10.97 M)(44.33 M)(37.56 M)(44.6 M)(48.12 M)
Earnings before Tax(42.55 M)(11.25 M)(47.11 M)(40.49 M)(45.26 M)(48.84 M)
Average Equity58.45 M50.8 M23.83 M(12.69 M)36.83 M55.8 M
Enterprise Value75.36 M34.89 M34.8 M119.15 M111.25 M114.18 M
Free Cash Flow(36 M)(4.71 M)(43.86 M)(35.78 M)(40.63 M)(43.84 M)
Invested Capital19.15 M3.88 M18.98 M1.11 M(8.32 M)(8.54 M)
Invested Capital Average29 M10.69 M20.72 M13.29 M(5.41 M)(5.55 M)
Market Capitalization102.94 M67.1 M54.75 M136.12 M200.28 M263.12 M
Tangible Asset Value59.35 M60.22 M49.01 M39.32 M84.78 M112.27 M
Working Capital46.79 M52.1 M34.88 M24.97 M68.97 M89.22 M

Infinity Fundamentals

About Infinity Pharmaceuti Fundamental Analysis

The Macroaxis Fundamental Analysis modules help investors analyze Infinity Pharmaceuti's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Infinity Pharmaceuti using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Infinity Pharmaceuti based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Last ReportedProjected for 2022
Deferred Revenue164.7 K169 K
Revenues1.9 M1.9 M
Revenue to Assets 0.05  0.05 
Revenue Per Employee85.7 K88 K
Infinity Pharmaceuticals, Inc., a biopharmaceutical company, focuses on developing novel medicines for people with cancer. Infinity Pharmaceuticals, Inc. was incorporated in 1995 and is headquartered in Cambridge, Massachusetts. Infinity Pharmaceuti operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange.

Infinity Pharmaceuti Investors Sentiment

The influence of Infinity Pharmaceuti's investor sentiment on the probability of its price appreciation or decline could be a good factor in your decision-making process regarding taking a position in Infinity. The overall investor sentiment generally increases the direction of a stock movement in a one-year investment horizon. However, the impact of investor sentiment on the entire stock markets does not have a solid backing from leading economists and market statisticians.

Infinity Pharmaceuti Implied Volatility

    
  90.36  
Infinity Pharmaceuti's implied volatility exposes the market's sentiment of Infinity Pharmaceuti stock's possible movements over time. However, it does not forecast the overall direction of its price. In a nutshell, if Infinity Pharmaceuti's implied volatility is high, the market thinks the stock has potential for high price swings in either direction. On the other hand, the low implied volatility suggests that Infinity Pharmaceuti stock will not fluctuate a lot when Infinity Pharmaceuti's options are near their expiration.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Infinity Pharmaceuti in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Infinity Pharmaceuti's short interest history, or implied volatility extrapolated from Infinity Pharmaceuti options trading.

Current Sentiment - INFI

Infinity Pharmaceuti Investor Sentiment

Most of Macroaxis users are currently bullish on Infinity Pharmaceuti. What is your judgment towards investing in Infinity Pharmaceuti? Are you bullish or bearish?
Bullish
Bearish
98% Bullish
2% Bearish

Becoming a Better Investor with Macroaxis

Macroaxis puts the power of mathematics on your side. We analyze your portfolios and positions such as Infinity Pharmaceuti using complex mathematical models and algorithms, but make them easy to understand. There is no real person involved in your portfolio analysis. We perform a number of calculations to compute absolute and relative portfolio volatility, correlation between your assets, value at risk, expected return as well as over 100 different fundamental and technical indicators.

Build Optimal Portfolios

Align your risk with return expectations

Fix your portfolio
By capturing your risk tolerance and investment horizon Macroaxis technology of instant portfolio optimization will compute exactly how much risk is acceptable for your desired return expectations
Please see Infinity Pharmaceuti Piotroski F Score and Infinity Pharmaceuti Altman Z Score analysis. Note that the Infinity Pharmaceuti information on this page should be used as a complementary analysis to other Infinity Pharmaceuti's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Insider Screener module to find insiders across different sectors to evaluate their impact on performance.

Complementary Tools for Infinity Stock analysis

When running Infinity Pharmaceuti price analysis, check to measure Infinity Pharmaceuti's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Infinity Pharmaceuti is operating at the current time. Most of Infinity Pharmaceuti's value examination focuses on studying past and present price action to predict the probability of Infinity Pharmaceuti's future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Infinity Pharmaceuti's price. Additionally, you may evaluate how the addition of Infinity Pharmaceuti to your portfolios can decrease your overall portfolio volatility.
Competition Analyzer
Analyze and compare many basic indicators for a group of related or unrelated entities
Go
Portfolio Comparator
Compare the composition, asset allocations and performance of any two portfolios in your account
Go
Probability Of Bankruptcy
Get analysis of equity chance of financial distress in the next 2 years
Go
Piotroski F Score
Get Piotroski F Score based on binary analysis strategy of nine different fundamentals
Go
Global Correlations
Find global opportunities by holding instruments from different markets
Go
Equity Search
Search for actively traded equities including funds and ETFs from over 30 global markets
Go
Money Flow Index
Determine momentum by analyzing Money Flow Index and other technical indicators
Go
Is Infinity Pharmaceuti's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Infinity Pharmaceuti. If investors know Infinity will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Infinity Pharmaceuti listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Market Capitalization
74.3 M
Quarterly Revenue Growth YOY
0.4
Return On Assets
-0.31
Return On Equity
-1.49
The market value of Infinity Pharmaceuti is measured differently than its book value, which is the value of Infinity that is recorded on the company's balance sheet. Investors also form their own opinion of Infinity Pharmaceuti's value that differs from its market value or its book value, called intrinsic value, which is Infinity Pharmaceuti's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Infinity Pharmaceuti's market value can be influenced by many factors that don't directly affect Infinity Pharmaceuti's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Infinity Pharmaceuti's value and its price as these two are different measures arrived at by different means. Investors typically determine Infinity Pharmaceuti value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Infinity Pharmaceuti's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.